Clinical trial
Long-Term Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On-Off" or "Wearing-Off" Effects Associated With Late-Stage Parkinson's Disease
NCT00142545 is registered in ClinicalTrials.gov with Mylan Bertek Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On-Off" or "Wearing-Off" Effects Associated With Late-Stage Parkinson's Disease
- Lead sponsor
- Mylan Bertek Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 1999
- Completion date
- July 31, 2005
- Enrollment
- 800
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.